News & Blog

Tag Archives: biopharma

Can this treatment help me live a longer and better life?

Why was I asked to sit on a panel with two top officials from the U.S. Food and Drug Administration (FDA), two leading neuro-oncologists, an associate professor of neuropsychiatry, and an executive from the biopharmaceutical company, Genentech? Because, as a five-year brain tumor survivor and volunteer advocate with the National Brain Tumor Society, I want […]

Creating Meaningful Change, With a Little Help From our Friends

There are only four FDA-approved therapies to treat brain tumors. And in the last 17 years there have been approximately 75 potential new drugs that have failed during the clinical trial process to prove they are safe and effective for patients, while only three that have won FDA approval[1]. That is a 25:1 failure ratio. […]

Making Sense of Project Impact: Preclinical testing

As part of our effort to raise awareness during Childhood Cancer Awareness Month, we created an infographic about our newest initiative that aims to get new and better treatments to children with brain tumors – Project Impact. Today, we want to spend some time talking about a major piece of that initiative, the so-called “preclinical […]

Share